Traders Should Watch: Petroleo Brasileiro Petrobras (NYSE:PBR), Itau Unibanco (NYSE:ITUB), PetMed Express, Inc. (NASDAQ:PETS), United Natural Foods, Inc. (NASDAQ:UNFI), Adamas Pharmaceuticals (NASDAQ:ADMS)

Three workers were seriously hurt in an explosion on Sunday at Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR)’ 323,000-barrel-a-day Landulpho Alves Refinery (RLAM) outside the northeastern city of Salvador, the second serious accident at Brazil’s second-largest refinery in a week. Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR) belongs to Basic Materials sector. Its net profit margin is 6.20% and weekly performance is 3.65%. On last trading day company shares ended up $6.81. Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR) distance from 50-day simple moving average (SMA50) is -18.31%.

Itau Unibanco Holding SA (NASDAQ:ITUB) has received a “BBB+” credit rating from Morningstar. The research firm’s “BBB+” rating suggests that the company is a moderate default risk. They also gave their stock a three star rating. Itau Unibanco Holding SA (ADR) (NYSE:ITUB) shares decreased -3.40% in last trading session and ended the day at $12.77. ITUB return on assets is 1.90%. Itau Unibanco Holding SA (ADR) (NYSE:ITUB) quarterly performance is -15.15%.

PetMed Express Inc. (NASDAQ:PETS) reported that its third-quarter net income was $4.8 million or $0.24 per share, up from last year’s $4.5 million or $0.23 per share in the prior year. Analysts polled by Thomson Reuters expected the company to report earnings of $0.22 per share for the quarter. Analysts’ estimates typically exclude special items. PetMed Express, Inc. (NASDAQ:PETS) belongs to Healthcare sector. Its net profit margin is 7.30% and weekly performance is 9.87%. On last trading day company shares ended up $15.70. PetMed Express, Inc. (NASDAQ:PETS) distance from 50-day simple moving average (SMA50) is 13.48%.

United Natural Foods (NASDAQ:UNFI) CFO Mark Shamber sold 2,449 shares of the stock in a transaction that occurred on Friday, January 16th. The stock was sold at an average price of $77.27, for a total value of $189,234.23. Following the completion of the transaction, the chief financial officer now directly owns 5,183 shares in the company, valued at approximately $400,490.41. United Natural Foods, Inc. (NASDAQ:UNFI) ended the last trading day at $78.55. Company weekly volatility is calculated as 2.89% and price to cash ratio as 223.15. United Natural Foods, Inc. (NASDAQ:UNFI) showed a weekly performance of 2.63%.

On Jan. 8, Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) announced that it has received a $30 million milestone payment from Forest Laboratories Holdings Limited, a subsidiary of Actavis plc, based on the recent FDA approval of Namzaric™, formerly known as MDX-8704. Adamas developed a fixed-dose combination of memantine hydrochloride extended-release (a NMDA receptor antagonist) and donepezil hydrochloride (an acetylcholinesterase inhibitor) initially, and Namzaric is the first and only such fixed-dose combination approved by the FDA for the treatment of moderate to severe dementia of the Alzheimer’s type in patients stabilized on memantine hydrochloride and donepezil hydrochloride. Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) shares increased 0.40% in last trading session and ended the day at $17.38. ADMS return on assets is 27.50%. Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) quarterly performance is 19.53%.